Toceranib phosphate
Catalog No. A15263
Toceranib phosphate是通过抑制KIT,血管内皮生长因子受体2和PDGFRβ而具有抗肿瘤和抗血管生成活性的激酶抑制剂。
Catalog Num | A15263 |
---|---|
M. Wt | 494.45 |
Formula | C22H28FN4O6P |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 874819-74-6 |
Synonyms | SU 11654, PHA 291639, SU11654, SU-11654, PHA-291639, PHA291639 |
SMILES | CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)C=C3C4=C(C=CC(=C4)F)NC3=O.OP(=O)(O)O |
Toceranib phosphate是通过抑制KIT,血管内皮生长因子受体2和PDGFRβ而具有抗肿瘤和抗血管生成活性的激酶抑制剂。
In vitro | DMSO | 2 mg/mL (4.04 mM) | |
Water | 2 mg/mL (4.04 mM) | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.22 mL | 101.12 mL | 202.24 mL |
0.5 mM | 4.04 mL | 20.22 mL | 40.45 mL |
1 mM | 2.02 mL | 10.11 mL | 20.22 mL |
5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
*The above data is based on the productmolecular weight 494.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.